| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/19/2005 | US6881826 Comprises receptor which binds compounds such as clonidine and idazoxan for identifying modulators of nervous system activity |
| 04/19/2005 | US6881825 Identication of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues |
| 04/19/2005 | US6881824 Peptides suitable for use in antigen specific immunosuppressive therapy |
| 04/19/2005 | US6881823 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing |
| 04/19/2005 | US6881822 Antibody for use in the treatment of tumors |
| 04/19/2005 | US6881789 A biopolymer containing a mixture of ubiquitin and at least one cross-linking agent which is selected from photoreactive or thermoreactive crosslinker |
| 04/19/2005 | US6881751 Medicament containing platinum complex compounds and the use thereof |
| 04/19/2005 | US6881722 Polypeptide Saratin for the manufacture of a medicament having the capability to significantly decrease platelet adhesion and platelet accumulation after vascular injuries or endarterectomy. The invention furthermore relates to novel |
| 04/19/2005 | US6881721 Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation |
| 04/19/2005 | US6881719 Binding to immunoglobulins; analyzing |
| 04/19/2005 | US6881718 Discovery of novel disulfide linked cell toxins which can ablate NK-1 receptor expressing cells. These toxins are used as pharmaceutical compositions for the ablation of NK1 receptor expressing cells and comprise a substance P |
| 04/19/2005 | US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents |
| 04/19/2005 | US6881564 Enzymatic peptide comprising modified asparaginic residues for treatment of tumors, infection, liver and autoimmune disorders |
| 04/19/2005 | US6881552 Human protease associated proteins |
| 04/19/2005 | US6881548 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 04/19/2005 | US6881546 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 04/19/2005 | US6881411 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 04/19/2005 | US6881409 Compositions and methods for promoting nerve regeneration |
| 04/19/2005 | US6881406 Administering an effective amount of a Chemokine receptor (CCR4) modulating agent, in a dose effective to modulate trafficking of systemic memmory T cells |
| 04/19/2005 | US6881404 Enzymatic protein for treating inflammation, thrombosis andrestenosis |
| 04/19/2005 | US6881403 For prophylaxis and therapy of vaginal infections |
| 04/19/2005 | US6881401 Methods of treatment of immune system related disorders using Neutrokine-alpha |
| 04/19/2005 | US6881398 Therapeutic dry powder preparation |
| 04/19/2005 | US6881395 Ligand for use as tool in the treatment of tumors in humans |
| 04/19/2005 | US6881200 Needleless syringe using super sonic gas flow for particle delivery |
| 04/19/2005 | CA2265252C Angiogenic factor and use thereof in treating cardiovascular disease |
| 04/19/2005 | CA2154447C In vitro maturation of oocytes with inhibin activin or inhibin/activin combinations |
| 04/19/2005 | CA2110497C Use of bacterial lipases for producing drugs for maldigestion therapy |
| 04/19/2005 | CA2059137C Enhancement of musculature in animals |
| 04/14/2005 | WO2005033705A1 Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating |
| 04/14/2005 | WO2005033694A2 Novel antisense oligomers and use thereof |
| 04/14/2005 | WO2005033325A1 Method of producing a recombinant polypeptide free of o-linked mannose residues |
| 04/14/2005 | WO2005033314A2 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/14/2005 | WO2005033311A2 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |
| 04/14/2005 | WO2005033310A1 Pim-1 specific dsrna compounds |
| 04/14/2005 | WO2005033308A1 Schizophrenia-associated protein and gene coding for the same |
| 04/14/2005 | WO2005033307A1 Novel refolding method and protein obtained by the method |
| 04/14/2005 | WO2005033272A2 In vivo synthesis of connective tissues |
| 04/14/2005 | WO2005033267A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 04/14/2005 | WO2005033141A1 Regulation of matrix metalloproteinases by psp94 family members |
| 04/14/2005 | WO2005033140A1 Highly pure blood coagulation factor ix preparation and method of purifying the same |
| 04/14/2005 | WO2005033137A1 Modified ciliary neurotrophic factor polypeptides with reduced antigenicity |
| 04/14/2005 | WO2005033136A1 Unique integrin binding site in connective tissue growth factor (ctgf) |
| 04/14/2005 | WO2005033134A2 Secreted protein therapeutics and uses thereof |
| 04/14/2005 | WO2005033129A1 Antibacterial amide macrocycles |
| 04/14/2005 | WO2005033068A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists |
| 04/14/2005 | WO2005032595A2 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 04/14/2005 | WO2005032581A2 Hybrid molecules having factor vii/viia activity |
| 04/14/2005 | WO2005032580A1 Methods and compositions for treating eosinophil mediated gastro-intestinal dysfunction or disease |
| 04/14/2005 | WO2005032579A1 Method of regenerating human tissue |
| 04/14/2005 | WO2005032578A1 Therapeutic method |
| 04/14/2005 | WO2005032577A1 Use of cyclosporin components in ophtalmic conditions |
| 04/14/2005 | WO2005032576A1 Therapeutic agent for hepatitis c |
| 04/14/2005 | WO2005032575A1 Protein kinase c peptides for use in withdrawal |
| 04/14/2005 | WO2005032574A1 Modulation of gastrointestinal epithelium proliferation through the wnt signaling pathway |
| 04/14/2005 | WO2005032573A1 Use of opioids in prevention of and recovery from a stress-induced crash in blood pressure |
| 04/14/2005 | WO2005032572A2 Means and methods for the recruitment and identification of stem cells |
| 04/14/2005 | WO2005032556A1 Method for reducing pain |
| 04/14/2005 | WO2005032511A2 Nanoparticulate therapeutic biologically active agents |
| 04/14/2005 | WO2005032496A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/14/2005 | WO2005032491A2 Methods and compositions for mycoplasma pneumoniae exotoxins |
| 04/14/2005 | WO2005032483A2 Polysaccharides for pulmonary delivery of active agents |
| 04/14/2005 | WO2005032482A2 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 04/14/2005 | WO2005032478A2 Treatment for diabetic microvascular and macrovascular complications |
| 04/14/2005 | WO2005032474A2 Pharmaceutical compositions for prevention of overdose or abuse |
| 04/14/2005 | WO2005032470A2 Compositions and methods for treating burns |
| 04/14/2005 | WO2005032469A2 METHODS FOR REGULATING BUD-HYPHA TRANSITION AND cAMP LEVELS IN CANDIDA ALBICANS |
| 04/14/2005 | WO2005032467A2 Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions |
| 04/14/2005 | WO2005032462A2 Glucocerebroside treatment of disease |
| 04/14/2005 | WO2005032461A2 Novel peptide with osteogenic activity |
| 04/14/2005 | WO2005032456A2 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production |
| 04/14/2005 | WO2005021026A3 Methods for treating or ameliorating ghrelin-associated diseases and disorders |
| 04/14/2005 | WO2005018663A8 G-csf derivative for inducing immunological tolerance |
| 04/14/2005 | WO2005016275A3 Formulations containing an immune response modifier |
| 04/14/2005 | WO2005014783A3 Reducing axon degeneration with proteasome inhibitors |
| 04/14/2005 | WO2005012485A3 Methods for treating diabetes and related disorders using pde10a inhibitors |
| 04/14/2005 | WO2005012347A3 Novel insulin derivatives |
| 04/14/2005 | WO2005011734A3 Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer |
| 04/14/2005 | WO2004110373A3 Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 04/14/2005 | WO2004096257A8 Genetic modification of targeted regions of the cardiac conduction system |
| 04/14/2005 | WO2004093892A3 Stanniocalcin-1, variant or antagonists thereof for selective modulation of vascularization |
| 04/14/2005 | WO2004092395A3 Modulators of telomere stability |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2004080957A3 Use of adnf polypeptides for treating anxiety and depression |
| 04/14/2005 | WO2004073624A3 Contraceptive methods and compositions related to proteasomal interference |
| 04/14/2005 | WO2004072275A3 Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge) |
| 04/14/2005 | WO2004072105A3 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
| 04/14/2005 | WO2004070054A3 Methods for preventing mitochondrial permeability transition |
| 04/14/2005 | WO2004058158A3 Treatment of metastatic cancer with the b-subunit of shiga toxin |
| 04/14/2005 | WO2004052311A3 Modulation of acteyl-coa acetyltransferase 2 expression |
| 04/14/2005 | WO2004048533A3 Modulation of forkhead box c2 expression |
| 04/14/2005 | WO2004037205A8 LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNFα ACTIVITY IS DETRIMENTAL |
| 04/14/2005 | WO2004031105A3 Use of a33 antigens and jam-it |
| 04/14/2005 | WO2004026228A3 Method for reducing morbidity and mortality in critically ill patients |
| 04/14/2005 | WO2004016739A3 Cell modulation using a cytoskeletal protein |
| 04/14/2005 | WO2004011485A3 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/14/2005 | WO2003073983A3 Methods and compositions in treating pain using diacylglycerol kinase epsilon |
| 04/14/2005 | WO2003070971A3 Modulators of paraptosis and related methods |
| 04/14/2005 | WO2003063573A3 Method for treating diseases with omega interferon |
| 04/14/2005 | WO2003053339A3 Insulin molecule having protracted time action |